AllSquare Wealth Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

AllSquare Wealth Management’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000	Closed	-$746	–	553
2024 Q4	$746	Hold	1,000	–	–	﹤0.01%	493
2024 Q3	$1.22K	Hold	1,000	–	–	﹤0.01%	481
2024 Q2	$2.07K	Hold	1,000	–	–	﹤0.01%	467
2024 Q1	$3.65K	Buy	+1,000	New	+$3.83K	﹤0.01%	442

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

AllSquare Wealth Management's OMGA Position: Q1 2025 in Review

AllSquare Wealth Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 1,000 shares — an estimated $746 sold.

AllSquare Wealth Management first reported a position in OMGA in Q1 2024 and held it in 4 quarters. The position peaked at $3.65K in Q1 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

AllSquare Wealth Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
AllSquare Wealth Management sold 1,000 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $746.
AllSquare Wealth Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
AllSquare Wealth Management's Omega Therapeutics, Inc. Common Stock position peaked at $3.65K in Q1 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on AllSquare Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.